COM:TMEPHARMA
TME Pharma N.V.
- Stock
Last Close
0.15
25/11 09:23
Market Cap
6.05M
Beta: -
Volume Today
744.63K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
net income | -13.79M - | -16.12M 16.88% | -10.72M 33.48% | -5.39M 49.75% | -10.74M 99.24% | -860K 91.99% | -10.41M 1,110% | -14.45M 38.88% | -15.13M 4.66% | -6.74M 55.47% | |
depreciation and amortization | 279K - | 218K 21.86% | 340K 55.96% | 29K 91.47% | 23K 20.69% | 47K 104.35% | 63K 34.04% | 66K 4.76% | 92K 39.39% | 144K 56.52% | |
deferred income tax | -7K - | -76K - | |||||||||
stock based compensation | 54K - | 275K 409.26% | 396K - | 396K 0% | 107K 72.98% | 162K 51.40% | 475K 193.21% | 589K 24% | |||
change in working capital | 467K - | 888K 90.15% | -877K 198.76% | 65K 107.41% | 320K 392.31% | -371K 215.94% | 363K 197.84% | 407K 12.12% | -720K 276.90% | 236K 132.78% | |
accounts receivables | |||||||||||
inventory | 1K - | 25K 2,400% | 13K 48% | ||||||||
accounts payables | 421K - | -580K 237.77% | |||||||||
other working capital | 466K - | 863K 85.19% | -890K 203.13% | -371K - | 363K 197.84% | -14K 103.86% | -140K 900% | 236K 268.57% | |||
other non cash items | 536K - | 1.26M 135.26% | 2.27M 80.10% | 662K 70.85% | 6.07M 817.52% | -3.21M 152.83% | 4.59M 243.16% | 1.12M 75.56% | 3.02M 169.10% | 721K 76.14% | |
net cash provided by operating activities | -12.46M - | -13.48M 8.21% | -8.99M 33.31% | -4.24M 52.88% | -4M 5.59% | -4.29M 7.15% | -5.22M 21.89% | -12.38M 137.00% | -12.14M 1.92% | -5.63M 53.59% | |
investments in property plant and equipment | -47K - | -8K 82.98% | -21K 162.50% | -2K 90.48% | -9K 350% | -16K 77.78% | -39K 143.75% | -14K 64.10% | -21K 50% | -19K 9.52% | |
acquisitions net | |||||||||||
purchases of investments | -5K - | -4.50M - | |||||||||
sales maturities of investments | 131K - | 4.50M - | |||||||||
other investing activites | 1K - | 25K - | 75K - | ||||||||
net cash used for investing activites | -41K - | -8K 80.49% | 4K 150% | 124K 3,000% | 66K 46.77% | -16K 124.24% | -39K 143.75% | -14K 64.10% | -21K 50% | -19K 9.52% | |
debt repayment | -305K - | -671K 120% | -39.00K - | ||||||||
common stock issued | 7.54M - | 1M 86.73% | 4.41M 341.40% | 1.52M 65.61% | 8.80M 479.51% | 7.22M 17.94% | 85K 98.82% | ||||
common stock repurchased | -17K - | -146K 758.82% | -4K - | -1K 75% | -29K 2,800% | -1K 96.55% | |||||
dividends paid | |||||||||||
other financing activites | 9.22M - | 16.73M 81.40% | -413K 102.47% | 1.67M 503.63% | 3.19M 91.24% | -121K 103.80% | 5.39M 4,553.72% | 4.28M 20.58% | 7.23M 68.90% | 3.31M 54.27% | |
net cash used provided by financing activities | 8.92M - | 16.06M 80.08% | 7.11M 55.73% | 2.52M 64.53% | 7.60M 201.55% | 1.40M 81.62% | 14.18M 915.18% | 11.50M 18.93% | 7.29M 36.64% | 3.27M 55.17% | |
effect of forex changes on cash | 49K - | 57K 16.33% | -1K 101.75% | ||||||||
net change in cash | -3.58M - | 2.57M 171.60% | -1.88M 173.23% | -1.59M 15.27% | 3.67M 330.40% | -2.90M 179.20% | 8.92M 407.02% | -848K 109.51% | -4.82M 468.63% | -2.39M 50.46% | |
cash at beginning of period | 5.11M - | 1.53M 70.12% | 4.09M 168.04% | 2.21M 45.91% | 622K 71.91% | 4.29M 589.71% | 1.39M 67.72% | 10.30M 643.97% | 9.46M 8.23% | 4.63M 50.99% | |
cash at end of period | 1.53M - | 4.09M 168.04% | 2.21M 45.91% | 622K 71.91% | 4.29M 589.71% | 1.39M 67.72% | 10.30M 643.97% | 9.46M 8.23% | 4.63M 50.99% | 2.25M 51.55% | |
operating cash flow | -12.46M - | -13.48M 8.21% | -8.99M 33.31% | -4.24M 52.88% | -4M 5.59% | -4.29M 7.15% | -5.22M 21.89% | -12.38M 137.00% | -12.14M 1.92% | -5.63M 53.59% | |
capital expenditure | -47K - | -8K 82.98% | -21K 162.50% | -2K 90.48% | -9K 350% | -16K 77.78% | -39K 143.75% | -14K 64.10% | -21K 50% | -19K 9.52% | |
free cash flow | -12.51M - | -13.49M 7.87% | -9.01M 33.19% | -4.24M 52.96% | -4.01M 5.43% | -4.30M 7.31% | -5.26M 22.34% | -12.39M 135.51% | -12.16M 1.86% | -5.65M 53.52% |
All numbers in EUR (except ratios and percentages)